Viewing Study NCT04415918


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2025-12-26 @ 4:05 AM
Study NCT ID: NCT04415918
Status: UNKNOWN
Last Update Posted: 2020-06-04
First Post: 2020-06-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bezlotoxumab Efficacy and Tolerability in Cancer Patient
Sponsor: The Cooper Health System
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module